Sildenafil Citrate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

71 API Suppliers, 20 USDMF, 21 CEP/COS, 5 JDMF, 18 EU WC, 13 KDMF, 26 NDC API, 46 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

35 Drugs in Development

35 Drugs in Development

INTERMEDIATES

12 API Suppliers

12 API Suppliers

FINISHED DOSAGE FORMULATIONS

550 FDF Dossiers, 98 FDA Orange Book, 181 Europe, 51 Canada, 36 Australia, 53 South Africa, 131 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SUSPENSION;ORAL - EQ 10MG BASE/ML, TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 25MG BASE, TABLET;ORAL - EQ 50MG BASE, TABLET;ORAL - EQ 20MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Rochem International Inc, 4 SPI Pharma, 2 Seqens, 5 DKSH, 2 Jai Radhe Sales, 2 Pharm-RX Chemical, 1 Chynops Pharma, 12 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 12 BASF, 1 Bioplus Life Sciences, 1 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Finar, 8 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 32 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 25 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

58 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 30 Controlled & Modified Release, 25 Direct Compression, 21 Thickeners and Stabilizers, 21 Lubricants & Glidants, 19 Disintegrants & Superdisintegrants, 17 Film Formers & Plasticizers, 15 Granulation, 14 Co-Processed Excipients, 13 Topical, 12 Parenteral, 11 Taste Masking, 7 Solubilizers, 7 Chewable & Orodispersible Aids, 6 API Stability Enhancers, 5 Empty Capsules, 5 Emulsifying Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

7 DATA COMPILATION #PharmaFlow, 219 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 84 Finished Drug Prices, 25 Annual Reports

MARKET PLACE

52 APIs, 9 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 4 US Exclusivities, 30 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 11 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 203109 / DOSAGE - FOR SUSPENSION;ORAL - EQ 10MG BASE/ML

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
SILDENAFIL CITRATE(UNII: BW9B0ZE037) (SILDENAFIL - UNII:3M7OB98Y7H)	SILDENAFIL	10mg in 1

Inactive Ingredients

Ingredient Name	Ascend Laboratories, LLC	Greenstone LLC	Lupin Pharmaceuticals, Inc.	Zydus Lifesciences Limited	Zydus Pharmaceuticals (USA) Inc.
ANHYDROUS CITRIC ACID(XF417D3PSL)
CARBOMER HOMOPOLYMER TYPE A(F68VH75CJC)
SILICON DIOXIDE(ETJ7Z6XBU4)
SODIUM BENZOATE(OJ245FE5EU)
SODIUM CITRATE(1Q73Q2JULR)
SORBITOL(506T60A25R)
SUCRALOSE(96K6UQ3ZD4)
TITANIUM DIOXIDE(15FIX9V2JP)
TRISODIUM CITRATE DIHYDRATE(B22547B95K)
XANTHAN GUM(TTV12P4NEE)

Drug Product Composition: Sildenafil Citrate